Carb-X

Clinical Workshop on Small Molecules and Biologicals
2023-01-19 15:00 - 17:00, 2023-01-26 15:00 - 17:00, 2023-02-02 15:00 - 17:00 (Europe/Berlin)
The DZIF Product Development Unit (PDU) invites you to the second part of our Clinical Workshop on Small Molecules and Biologicals, which will take place in January and February 2023 as an online format. This second part of the workshop is independent from the first one, therefore knowledge of the first part or other workshops of this series is not required.

The workshop will cover different aspects of clinical trial design and the application process. Experts from regulatory bodies, ethics committee, industry and supporting infrastructures as well as DZIF scientists will provide relevant guidance and share their experience in clinical trial planning and conduct.

The workshop will be held as a weekly webinar over the course of three weeks with the following topics:

Session 1: Introduction on clinical development
Thursday 19th January 2023, start at 3 pm (CET)
Session 2: Role of ethics committee and supporting infrastructures
Thursday 26th January 2023, start at 3 pm (CET)
Session 3: Regulatory background of clinical studies
Thursday 2nd February 2023, start at 3 pm (CET)

For further information, please see the agenda attached.

For registration, please contact OSRA@PEI.de until 12th of January 2023 including if you are affiliated with DZIF or CARB-X.

CARB-X Funding Rounds Q&A #2
2023-01-20 19:00 - 20:00 (America/New_York)
Register here for the 2nd of 2 Q&A sessions on the upcoming CARB-X funding rounds

ANTIMICROBIAL CHEMOTHERAPY CONFERENCE (ACC 2023)
2023-02-01 08:00 - 2023-02-02 17:00 (America/New_York)
This virtual conference is jointly organised by BSAC and GARDP. For ACC2023, the collaborating organisations are Africa CDC and ReAct Africa.

2023 UNIVERSAL HEALTH COVERAGE (UHC) IN AN ERA OF ANTIMICROBIAL RESISTANCE (AMR) AND PANDEMICS CONFERENCE
2023-02-21 08:00 - 2023-02-22 17:00 (America/New_York) | Tokyo Station Hotel
Built upon the outcomes of the 2018 High-level Meeting spearheaded by ASEF, the high-level conference on “Universal Health Coverage (UHC) in an Era of Antimicrobial Resistance (AMR) and Pandemics” is co-organised by Asia-Europe Foundation (ASEF), AMR Clinical Reference Center and the Ministry of Foreign Affairs of Japan. The conference will take place on 21-22 February 2023 in Tokyo, Japan.
The overall aim of this conference is to facilitate a much-needed dialogue between governments and other stakeholders on practical ways to integrate a concern for AMR into UHC. Unlike short-term measures and funding schemes, health systems are here to stay. Accordingly, the conference will discuss sustainable actions on AMR using the health system approach. Actionable AMR strategies that address the need to support high quality science and provide incentives to develop and produce new antimicrobials will also be considered. The conference will explore the links between mitigating AMR under UHC and pandemic preparedness. Last but not least, possible international collaborations and effective coordination mechanisms will also be sought, as AMR cannot be solved by a single country on its own.
The conference will bring together senior-level health officials who are working in the areas of UHC, AMR, and Pandemic Preparedness and Response (PPR). The conference will feature presentations and panel discussions on topical subjects, such as about innovative ideas on R&D and commercialisation of antimicrobials for sustainability, as well as group discussions on priorities for international cooperation between Asia and Europe to support progress towards sustainable UHC while containing risks of emerging infectious diseases, including AMR.
To learn more about the conference background, its audience, partners, and other details, please click here.
This high-level conference is an invitation-only event.

Webinar: Addressing Antimicrobial Resistance Through the Pandemic Instrument
2023-02-21 10:30 - 11:30 (America/New_York)
This moment provides an important opportunity for addressing the global threat of antimicrobial resistance (AMR).
This month, the Intergovernmental Negotiating Body (INB) –– the entity established by the World Health Organization (WHO) to draft and negotiate a pandemic instrument –– will meet to consider and negotiate the zero draft of the WHO international instrument on pandemic prevention, preparedness and response. This webinar will contribute to discussions on the pandemic instrument and the opportunity to comprehensively address the full range of pandemic threats, including AMR. AMR already kills over 1 million people annually and contributes to millions more deaths around the world – a toll that is disproportionately borne by LMICs.
Join us for a discussion and exchange inspired by the forthcoming Symposium Issue of the Journal of Law, Medicine & Ethics (JLME) on Addressing Antimicrobial Resistance through the Pandemic Instrument, guest edited by Kevin Outtersen (Boston University, CARB-X) and Global Strategy Lab’s Susan Rogers Van Katwyk and Steven J. Hoffman. The webinar will feature a roundtable format, a panel of researchers and experts on AMR policy and will be followed by a Q&A session with the audience.

BIOCOM 2023
2023-02-28 08:00 - 2023-03-02 17:00 (America/New_York)
The Premier Partnering Event of the Year
This conference is an exclusive global partnering forum that brings together senior executives, bankers, venture capitalists, and business development professionals from leading pharmaceutical and biotech companies. Join us next February 2023, where industry leaders will debate current trends, companies will showcase their latest technologies and all attendees will have the opportunity to schedule one-on-one meetings with leading deal-makers from around the globe.

An Unfinished Life: The True Impact of Antibiotic Resistance
2023-03-03 08:00 - 2023-03-16 17:00 (America/New_York)
Join Australia’s mission against superbugs with the Australian Premiere of Salt in my Soul followed by an interactive discussion forum with the scientists, clinicians and policy makers working at the coalface of antimicrobial resistance.
Speakers include CARB-X’s Chief Scientist, Dr. Richard Alm
March 3rd: Perth
March 7th: Brisbane
March 10th: Adelaide
March 14th: Melbourne
March 16th: Sydney

7th AMR Conference
2023-03-16 08:00 - 2023-03-17 17:00 (America/New_York)
The #AMRconference is a platform for SMEs, start-ups, big pharma, academia, investors and public institutions to discuss strategies and the specific challenges faced by SMEs in bringing new antimicrobial treatments and diagnostics to the market.
The “AMR Conference” was started in 2017 as part of the annual “Berlin Conference on Life Sciences” series which was established by BIOCOM AG twelve years ago as an event format to discuss the challenges of SME-driven innovation for the health market and to offer a platform for meeting experts from business, science, clinics, finance, regulatory affairs and intellectual property.

The BEAM Alliance is one of the major supporting partners of the AMR Conference. Launched in June 2015, the BEAM (Biotech companies in Europe combating AntiMicrobial Resistance) Alliance is a strong network of more than 60 small and medium-sized European biotech and diagnostics companies committed to developing innovative products for fending off antibiotic-resistant pathogens. The aim is to establish the AMR Conference as the one-stop-shop in Europe to meet all AMR relevant stakeholders.

ECCMID 2023
2023-04-15 08:00 - 2023-04-18 17:00 (America/New_York)
ECCMID invites you to the 33rd European Congress of Clinical Microbiology & Infectious Diseases, which will take place as a hybrid event both online and in Copenhagen, Denmark on 15 – 18 April 2023.

CARB-X Funding Rounds Q&A #1
2023-04-20 18:00 - 19:00 (America/New_York)
Register here for the 1st of 2 Q&A sessions on the upcoming CARB-X funding rounds.

CARB-X Funding Rounds Q&A #2
2023-04-21 08:00 - 09:00 (America/New_York)
Register here for the 2nd of 2 Q&A sessions on the upcoming CARB-X funding rounds.

Financial Times Live Panel: National health security – Addressing rising threats
2023-05-17 13:35 - 14:20 (America/New_York) | VIRTUAL EVENT
The coronavirus pandemic was a wake-up call for those inclined to ignore emerging health threats. Looking to the future, whether it be another virus, mental health, or noncommunicable diseases such as diabetes and dementia, the US must consider its options to avoid or at least minimize the impact of health threats with the potential to cause even more pain if ignored.

How can stakeholders work together to prepare for epidemics and pandemics of the future?
What can be done to support health systems in handling the rise of chronic conditions such as obesity and dementia?
What advances are we seeing in treatment of increasingly prevalent conditions such as Alzheimer’s, diabetes and cancer?
As recognition and understanding of mental health evolves, how could treatments change?

Speakers:
Kevin Outterson, Austin B. Fletcher Professor, Boston University, Executive Director and Principal Investigator, CARB-X
Rasmus Besch Hansen, CEO and Founder, Airfinity
Olivier Bogillot, Head of US General Medicines, Sanofi
Julie Gerberding, CEO, Foundation for the National Institutes of Health
Andrew Jack, Global Education Editor, Financial Times

BSAC Spring Conference
2023-05-18 08:00 - 2023-05-19 17:00 (America/New_York)
ADDRESSING THE AMR BURDEN IN EVERYDAY PRACTICE

76th World Health Assembly
2023-05-21 08:00 - 2023-05-30 17:00 (America/New_York)
The World Health Assembly is the decision-making body of WHO. It is attended by delegations from all WHO Member States and focuses on a specific health agenda prepared by the Executive Board. The main functions of the World Health Assembly are to determine the policies of the Organization, appoint the Director-General, supervise financial policies, and review and approve the proposed programme budget. The Health Assembly is held annually in Geneva, Switzerland.

BIO Boston 2023
2023-06-05 08:00 - 2023-06-08 17:00 (America/New_York) | Boston Convention Center, 415 Summer St, Boston, MA, 02210, United States
Stand up for innovation. Stand up for truth. And stand up for science. It’s time to inspire, honor, and recognize the true value of the breakthrough work biotech performs for society. Today. And every day. Well into the future.

Engaging the Pharmaceutical Industry in Joint Efforts to Tackle ANTIMICROBIAL RESISTANCE
2023-06-10 15:00 - 17:30 (Asia/Kolkata)
A webinar focused on AMR issues pertinent to India such as:

What is the current status of antibiotic development in the pipeline, both in India and globally?
What are some potential strategies or incentives to stimulate anti-infective development in India?
What role can the Indian pharmaceutical industry play in global efforts to develop new anti-infectives?
How can we ensure the availability and affordability of new antibiotics in India while maintaining their responsible use?

Register here to join the conversation.

Boston Bacterial Meeting 2023
2023-06-12 08:00 - 2023-06-13 17:00 (America/New_York) | Harvard Science Center
The meeting will be held at the Harvard Science Center, 1 Oxford St, Cambridge, MA 02138. Please visit our Directions page for information on public transit and parking.

The keynote address for BBM 2023 will be delivered by Dr. Kumaran Ramamurthi from the NIH. Dr. Ramamurthi is a renowned bacterial cell biologist who has made important contributions to our understanding of how morphogenetic proteins localize to specific sites and drive essential processes such as spore formation and cell division. Please visit our Keynote Speaker page for more information about his career and accomplishments.

About BBM

BBM was founded in 1995 by two postdocs from Richard Losick’s lab at Harvard, Kit Pogliano and Karen McGovern, with the goal of bringing bacteriologists from the greater Boston area together to present their work and share ideas. BBM, now in its 29th year, has proven to be a vibrant meeting, attended not only by bacteriologists from the Boston area but from all over the country. Keeping with its roots, the conference is being planned and organized by a committee of students, postdocs, and other early career researchers. This year, the organizational committee is co-chaired by Alam García-Heredia, a postdoc in Alan Grossman’s lab at MIT, and Shailab Shrestha, a graduate student in Aimee Shen’s lab at Tufts.

ASM Microbe 2023
2023-06-15 08:00 - 2023-06-19 17:00 (America/New_York) | George R. Brown Convention Center, Houston, TX
Join thousands of scientists, researchers and healthcare professionals in your field, who are all traveling to Houston, TX from June 15-19 for the largest microbial sciences gathering in the world! Andy Weir, John Nkengasong and Edward Holmes are just some of the world-renowned speakers lined up in ASM Microbe’s cutting-edge scientific program.
Plus, do you have late-breaking research? There is still time to join our robust scientific program! Emerging Abstract Submissions Opens April 4. Don’t miss the opportunity to present your research and learn about the latest science from experts and leaders in your field.
ASM Microbe 2023 will cover:

Disaster Microbiology.
Emerging Infections – What is the Next pandemic? (Focus on Nipah and Marburg).
Natural Product Discovery and Synthesis.
The Next Generation Antifungal Agents: Clinical Application and Resistance.
Combating the Climate Crisis with Critters: Microbial Carbon Capture.
Powering the Future: Applied Microbiology in the Energy Industry.
Equity and Access in Laboratory Diagnostics.
Microbiome Management in a Changing World.
New Perspectives on Phage Therapy to Treat Multidrug Resistant Infections.
Beyond Academia: Fulfilling Microbiology Careers Outside the Tenure Track.
The Perks of Being Squishy: Archaea as a Skillful Mechanoresponsive Machine.
What is the Microbiota Really Doing in Neuroinflammatory Diseases?
And so much more!

ACS Fall Meeting - The Future of Antibiotic Drug Discovery
2023-08-13 08:00 - 2023-08-17 17:00 (America/New_York) | San Francisco, CA
Where thousands of chemistry professionals meet to share ideas and advance scientific and technical knowledge.

World AMR Congress 2023
2023-09-07 08:00 - 2023-09-08 17:00 (America/New_York) | Pennsylvania Convention Center, Philadelphia, PA
THE WORLD’S LARGEST AMR CONFERENCE FOR ALL STAKEHOLDERS COMBATING ANTI-MICROBIAL RESISTANCE

2023 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
2023-09-19 08:00 - 2023-09-22 17:00 (America/New_York) | Boston, MA
The 2023 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance is scheduled to take place Sept. 19-22, 2023 in Boston, Mass.
Co-sponsored by ASM and the European Society for Clinical Microbiology and Infectious Diseases (ESCMID), this multidisciplinary meeting will highlight the challenges, opportunities and current requirements for antimicrobial drug development to address antimicrobial resistance.

Canada Webinar
2023-10-05 13:00 - 14:00 (America/New_York)
You are invited to an exclusive webinar for Canada by CARB-X on Thursday, Oct. 5th at 1pm Eastern. This webinar will highlight the importance of antibacterial R&D, provide an overview of CARB-X, and describe how Canadian organizations and individuals may work with CARB-X in the future, including receiving financial, scientific, regulatory and business support. The presenters will be Richard Alm, the Chief Scientist of CARB-X, and Rich Lawson, a member of the CARB-X executive team. There will be approximately 30 minutes of presentation and then time for questions and answers.
Please click here to register.

ID Week 2023
2023-10-11 08:00 - 2023-10-15 17:00 (America/New_York) | Boston Convention Center, 415 Summer St, Boston, MA, 02210, United States
IDWeek is the joint annual meeting of the Infectious Diseases Society of America (IDSA), Society for Healthcare Epidemiology of America (SHEA), the HIV Medicine Association (HIVMA), the Pediatric Infectious Diseases Society (PIDS), and the Society of Infectious Diseases Pharmacists (SIDP).

World Health Summit 2023
2023-10-15 08:00 - 2023-10-17 17:00 (America/New_York) | Berlin, Germany
The World Health Summit is the unique international strategic forum for global health. Held annually in Berlin, it brings together stakeholders from politics, science, the private sector, and civil society from around the world to set the agenda for a healthier future by inspiring innovative solutions for better health and well-being for all.
The World Health Summit was founded in 2009 on the occasion of the 300th anniversary of Charité – Universitätsmedizin Berlin. It is traditionally held under the patronage of the German Chancellor, the French President, the President of the European Commission, and the Director-General of the World Health Organization (WHO). President of the World Health Summit is Axel R. Pries, Dean of Charité.
In addition to the World Health Summit in Berlin, there are annual Regional Meetings and regular Expert Meetings around the world. These meetings are organized by the M8 Alliance, the academic backbone of the World Health Summit.

BSAC Winter Conference 2023
2023-11-30 08:00 - 2023-12-01 17:00 (America/New_York)
Infection 2023: BSAC Winter Conference – Addressing AMR across the tightrope of politics, policy and practice

Lorne Infection & Immunity 2024
2024-02-14 08:00 - 2024-02-16 17:00 (America/New_York)
The Lorne Infection and Immunity Conference brings together scientists, students, health care and industry from multiple disciplines with a shared interest in infection and immunity research.
Registrations are open and abstracts are now being accepted.
ECR awards, subsidised student registrations, an amazing speaker list, networking and social events, and the return to our face-to-face meeting format combined with the advantages of online participation, mean participation is accessible to everyone and there is every reason to join in.
See below for links to register and for more information.
2024 THEMES
Host-pathogen interactions
Molecular basis of infectious diseases
Innate immunity
Adaptive immunity
Advances in immunotherapy vaccines and clinical translation
New solutions for antimicrobial resistance
Emerging infectious diseases and global health

8th AMR Conference
2024-03-06 08:00 - 2024-03-07 17:00 (America/New_York)
The #AMRconference is a platform for SMEs, start-ups, big pharma, academia, investors and public institutions to discuss strategies and specific challenges faced by the innovation ecosystem in bringing new antimicrobial treatments and diagnostics to the market.
The conference is the one-stop shop to catch up with the latest trends in the development of AMR products, by covering scientific, regulatory, financial and policy topics. Besides high-level talks, the conference is a great place to network and exchange views on innovative technologies, development paths and alternative business models with your peers. The conference also offers a partnering platform to facilitate interactions.
The 7th edition covered the whole innovation value chain, including scientific breakthrough, preclinical and clinical development, but also financial topics such as public funding for R&D, market incentive and investors’ perspective. Specific sessions were also dedicated to antimicrobials in the environment, diagnostics, antifungals, biologics and anti-tuberculosis drug combinations. There was a special focus on India and how the country is getting prepared to provide global solutions against AMR. Among other highlights were a start-up competition, hosted by the pharma-backed incubator INCATE, and a poster prize.

The AMR Conference is jointly organized by BEAM Alliance and bamconn GmbH.
The BEAM Alliance is one of the major supporting partners of the AMR Conference. Launched in June 2015, the BEAM (Biotech companies in Europe combating AntiMicrobial Resistance) Alliance gathers more than 70 small and medium-sized European biotech and diagnostics companies committed to developing innovative products for fending off antibiotic-resistant pathogens. BEAM Alliance carries the voice of SMEs to support policies and incentives in antimicrobial research and development in Europe.
bamconn GmbH was established in November 2022 as a spin-off of BIOCOM AG and continues its entire event management as an independent company. It is built on more than 15 years of experience in the planning, organization and implementation of scientific events and exhibitions. The portfolio covers the entire spectrum from small workshops with 20 participants to multi-day international conferences for up to 2,000 people as well as exhibitions on the topic of bioeconomy throughout Europe. Customers for whom the bamconn team worked so far are companies, research institutions, associations and federal ministries as well as subordinate authorities and EU-funded projects.

Antimicrobial Resistance - Genomes, Big Data and Emerging Technologies
2024-03-13 08:00 - 2024-03-15 17:00 (America/New_York)
Antimicrobial resistance (AMR) is a major challenge in our globalised world, and tackling it will take the combined resources and effort of researchers working across different disciplines. Technical advances in recent years continue to expand our ability to collect vast amounts of genomic information on pathogens, and a wealth of data is being collected in epidemiological and surveillance studies, including on the socio-economic burden of AMR.
Our 4th conference in this series will bring together basic researchers, clinicians, computer scientists, and policymakers interested in pathogen genomics, epidemiology, surveillance, and machine learning to explore the recent advances and current challenges of the field.
This year’s programme will once again focus on genomic evidence and how to implement it in clinical practice and policy for AMR control. The meeting will highlight the advances in machine learning, AI and computational tools to predict AMR. We will also discuss how to build an international genomics infrastructure to tackle AMR and emerging lessons from other global public health issues.
This conference will be a hybrid meeting – with onsite or virtual attendance. In addition to invited talks, the programme will include short oral presentations selected from abstracts, posters, poster pitches and networking breaks for further discussion.
